120
Participants
Start Date
October 31, 2012
Primary Completion Date
July 11, 2017
Study Completion Date
July 11, 2017
Pazopanib
Doxorubicin
University Hospitals Leuven, Leuven Cancer Institute, Dept. of General Medical Oncology, Leuven
Charité Hospital, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Berlin
Hannover Medical School, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hanover
University Hospital Essen, West-German Tumor Center, Essen
University Hospital Cologne, Cologne
University Hospital RWTH Aachen, Medical Dept. IV, Aachen
University Medical Centre Mannheim, Surgical oncology, Mannheim
Heidelberg University Hospital, Department of Internal Medicine, Hematology, Oncology and Rheumatology, Heidelberg
Medical University Tuebingen, Center for Soft Tissue Sarcoma, GIST and Bone Tumors, Tübingen
LMU University hospital Munich Grosshadern, Medical Dept. III, Munich
University Hospital Carl Gustav Carus, Internal Medicine Dept. I, Dresden
Hannover Medical School
OTHER